A Systematic Review and Meta-Analysis of Cancer Patients Affected by a Novel Coronavirus

2021124 citationsReviewgold Open Access

Authors

Bhanu Prasad Venkatesulu · Loyola University Chicago

Viveksandeep Thoguluva Chandrasekar · University of Kansas Medical Center

Prashanth Girdhar · All India Institute of Medical Sciences

Pragati Advani · National Institutes of Health

Amrish Sharma · The University of Texas MD Anderson Cancer Center

Thiraviyam Elumalai · The Christie NHS Foundation Trust

Cheng‐En Hsieh

Abstract

Cancer patients with COVID-19 disease are at increased risk of mortality and morbidity. A more nuanced understanding of the interaction between cancer-directed therapies and COVID-19-directed therapies is needed. This will require uniform prospective recording of data, possibly in multi-institutional registry databases.

Topics & Keywords

COVID-19 and healthcare impacts Infection Control and Ventilation

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: JNCI Cancer Spectrum

Volume 5, Issue 2, pp. pkaa102-pkaa102

DOI: 10.1093/jncics/pkaa102

Field-Weighted Citation Impact: 8.85